Low dose synthetic prostaglandin E2: always safe for pregnancy termination?
Jeurissen
S E R
SE
Department of Obstetrics and Gynecology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
Harinck
H I J
HI
Oepkes
D
D
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000032:Abortion, Therapeutic / Q000009:adverse effects*; D000328:Adult; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D015232:Dinoprostone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005260:Female; D017359:HELLP Syndrome / Q000188:drug therapy; D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use; D011247:Pregnancy; D014597:Uterine Rupture / Q000175:diagnosis / Q000209:etiology*
D000020:Abortifacient Agents, Nonsteroidal; C016767:sulprostone; D007650:Ketanserin; D015232:Dinoprostone